Cure Stream Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
20
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
13
Cure Stream General Information
Description
Operator of a laboratory intended for researching and developing future medical treatments for chronic diseases such as diabetes. The company develops a fully autonomous artificial pancreas system based on an artificial intelligence-based hormone injection decision algorithm, enabling patients to improve the quality of life caused by diseases.
Contact Information
Website
www.curestream.co.krCorporate Office
- 2nd floor, Makerspace Building
- 51 Hoam-ro, Buk-gu
- Daegu, Gyeongsang
- South Korea
Corporate Office
- 2nd floor, Makerspace Building
- 51 Hoam-ro, Buk-gu
- Daegu, Gyeongsang
- South Korea
Cure Stream Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 5. Later Stage VC (Series A) | 07-May-2025 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Jan-2021 | Completed | Generating Revenue | |||
| 3. Seed Round | 24-Mar-2020 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Cure Stream Patents
Cure Stream Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026054240-A1 | Filling guide for injecting liquid medicine into liquid medicine injection device, and liquid medicine injection device having same | Pending | 09-Sep-2024 | ||
| WO-2026043019-A1 | Module separation tool of medical liquid injection device | Pending | 22-Aug-2024 | ||
| US-20250239350-A1 | Insulin dosage determination system based on personalized artificial intelligence | Pending | 19-Jan-2024 | ||
| WO-2025154971-A1 | Personalized artificial intelligence-based insulin dose determination system | Pending | 19-Jan-2024 | ||
| US-20250121130-A1 | Apparatus for infusing medical liquid equipped with a piston operation detection sensor | Pending | 12-Oct-2023 | A61M5/16831 |
Cure Stream Signals
Cure Stream Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Devsisters Ventures | Corporate Venture Capital | Minority | ||
| Innopolis Partners | Venture Capital | Minority | ||
| Korea Credit Guarantee Fund | Venture Capital | Minority | ||
| Murex Partners | Venture Capital | Minority | ||
| Smilegate Investment | Venture Capital | Minority |
Cure Stream FAQs
-
When was Cure Stream founded?
Cure Stream was founded in 2019.
-
Where is Cure Stream headquartered?
Cure Stream is headquartered in Daegu, South Korea.
-
What is the size of Cure Stream?
Cure Stream has 20 total employees.
-
What industry is Cure Stream in?
Cure Stream’s primary industry is Other Healthcare Technology Systems.
-
Is Cure Stream a private or public company?
Cure Stream is a Private company.
-
What is Cure Stream’s current revenue?
The current revenue for Cure Stream is .
-
How much funding has Cure Stream raised over time?
Cure Stream has raised $7.68M.
-
Who are Cure Stream’s investors?
Devsisters Ventures, Innopolis Partners, Korea Credit Guarantee Fund, Murex Partners, and Smilegate Investment are 5 of 13 investors who have invested in Cure Stream.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process